Published in Curr Protoc Toxicol on August 01, 2016
Deficiencies in mitochondrial dynamics sensitize Caenorhabditis elegans to arsenite and other mitochondrial toxicants by reducing mitochondrial adaptability. Toxicology (2017) 0.77
Effects of reduced mitochondrial DNA content on secondary mitochondrial toxicant exposure in Caenorhabditis elegans. Mitochondrion (2016) 0.76
IDH1 and IDH2 mutations in gliomas. N Engl J Med (2009) 32.41
Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature (2003) 26.58
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69
Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (1999) 14.41
Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science (2000) 8.64
Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab (2007) 7.07
Mitochondria: more than just a powerhouse. Curr Biol (2006) 6.76
Mitochondria and cancer. Nat Rev Cancer (2012) 4.81
Rotenone, paraquat, and Parkinson's disease. Environ Health Perspect (2011) 3.87
Basic culture methods. Methods Cell Biol (1995) 3.87
Mitochondria take center stage in aging and neurodegeneration. Ann Neurol (2005) 3.83
Mitochondrial retrograde signaling. Annu Rev Genet (2006) 3.75
Mitochondria and calcium: from cell signalling to cell death. J Physiol (2000) 3.73
Characterization of a germ-line proliferation mutation in C. elegans. Development (1992) 3.70
Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet (2012) 3.47
Metabolic labeling of C. elegans and D. melanogaster for quantitative proteomics. Nat Biotechnol (2003) 2.37
Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res (1997) 2.21
The million mutation project: a new approach to genetics in Caenorhabditis elegans. Genome Res (2013) 2.20
Inhibition by malonate of succinic dehydrogenase in heart-muscle preparations. Biochem J (1953) 1.82
Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo[a]pyrene. Science (1980) 1.78
The significance of mitochondrial toxicity testing in drug development. Drug Discov Today (2007) 1.56
Assaying metabolic activity in ageing Caenorhabditis elegans. Mech Ageing Dev (2002) 1.53
Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. J Clin Invest (1972) 1.46
Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci (Lond) (2008) 1.41
Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity. Mitochondrion (2010) 1.28
Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors. J Med Chem (2012) 1.27
Mitochondria as a target of environmental toxicants. Toxicol Sci (2013) 1.24
Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. Biochem Pharmacol (1996) 1.22
The role of mitochondria in the life of the nematode, Caenorhabditis elegans. Biochim Biophys Acta (2003) 1.18
Germline signals deploy NHR-49 to modulate fatty-acid β-oxidation and desaturation in somatic tissues of C. elegans. PLoS Genet (2014) 1.06
Development and application of bioluminescent Caenorhabditis elegans as multicellular eukaryotic biosensors. FEBS Lett (2001) 1.04
Mitochondrial dynamics and autophagy aid in removal of persistent mitochondrial DNA damage in Caenorhabditis elegans. Nucleic Acids Res (2012) 1.02
Disruption of insulin signalling preserves bioenergetic competence of mitochondria in ageing Caenorhabditis elegans. BMC Biol (2010) 1.02
Bridging the phenotypic gap: real-time assessment of mitochondrial function and metabolism of the nematode Caenorhabditis elegans. BMC Physiol (2008) 1.01
Discovery of anthelmintic drug targets and drugs using chokepoints in nematode metabolic pathways. PLoS Pathog (2013) 1.00
Effects of early life exposure to ultraviolet C radiation on mitochondrial DNA content, transcription, ATP production, and oxygen consumption in developing Caenorhabditis elegans. BMC Pharmacol Toxicol (2013) 0.97
Intermediary metabolism. WormBook (2009) 0.90
Rapid sublethal toxicity assessment using bioluminescent Caenorhabditis elegans, a novel whole-animal metabolic biosensor. Toxicol Sci (2009) 0.90
Drug absorption efficiency in Caenorhbditis elegans delivered by different methods. PLoS One (2013) 0.90
Mitochondrial dysfunction confers resistance to multiple drugs in Caenorhabditis elegans. Mol Biol Cell (2010) 0.86
Effects of 5'-fluoro-2-deoxyuridine on mitochondrial biology in Caenorhabditis elegans. Exp Gerontol (2014) 0.86
Increased local metabolic rate by free fatty acids in the intact dog heart. Scand J Clin Lab Invest (1971) 0.85
Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis? Carcinogenesis (2015) 0.85
Seahorse Xf(e) 24 Extracellular Flux Analyzer-Based Analysis of Cellular Respiration in Caenorhabditis elegans. Curr Protoc Toxicol (2015) 0.83
Arsenite-induced pseudo-hypoxia results in loss of anchorage-dependent growth in BEAS-2B pulmonary epithelial cells. PLoS One (2014) 0.82
Developmental Effects of the ToxCast™ Phase I and Phase II Chemicals in Caenorhabditis elegans and Corresponding Responses in Zebrafish, Rats, and Rabbits. Environ Health Perspect (2015) 0.80
Impact of sublethal levels of environmental pollutants found in sewage sludge on a novel Caenorhabditis elegans model biosensor. PLoS One (2012) 0.79
A High-Throughput Method for the Analysis of Larval Developmental Phenotypes in Caenorhabditis elegans. Genetics (2015) 0.79
A Screenable In Vivo Assay for Mitochondrial Modulators Using Transgenic Bioluminescent Caenorhabditis elegans. J Vis Exp (2015) 0.78
The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces mitochondrial and nuclear DNA damage in Caenorhabditis elegans. Environ Mol Mutagen (2013) 0.78
Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy. Curr Opin Pediatr (2015) 0.78
From the Cover: Arsenite Uncouples Mitochondrial Respiration and Induces a Warburg-like Effect in Caenorhabditis elegans. Toxicol Sci (2016) 0.77
Seahorse Xf(e) 24 Extracellular Flux Analyzer-Based Analysis of Cellular Respiration in Caenorhabditis elegans. Curr Protoc Toxicol (2015) 0.83
PCR-Based Analysis of Mitochondrial DNA Copy Number, Mitochondrial DNA Damage, and Nuclear DNA Damage. Curr Protoc Toxicol (2016) 0.77
Caenorhabditis elegans as a Model for Toxic Effects of Nanoparticles: Lethality, Growth, and Reproduction. Curr Protoc Toxicol (2015) 0.77